Literature DB >> 20031051

Pandemic (H1N1) 2009 surveillance and prevalence of seasonal influenza, Singapore.

Yee Sin Leo1, David C Lye, Timothy Barkham, Prabha Krishnan, Eillyne Seow, Angela Chow.   

Abstract

On April 25, 2009, Singapore implemented strict containment measures for pandemic (H1N1) 2009 with enhanced surveillance and hospital isolation. In the first month, seasonal influenza, predominantly virus subtype H3N2, was diagnosed for 32% of patients with acute febrile respiratory illness. Our findings underscore the high prevalence of seasonal influenza in Singapore.

Entities:  

Mesh:

Year:  2010        PMID: 20031051      PMCID: PMC2874379          DOI: 10.3201/eid1601.091164

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Tropical countries experience influenza year round, with 2 peaks corresponding to the rainy seasons (). Despite this year-round activity, seasonal influenza is often neglected in tropical countries in terms of clinical diagnosis, treatment, and vaccination (). In Singapore, influenza activity usually peaks in June and December (). The annual all-cause death rate from seasonal influenza in Singapore has been estimated at 14.8/100,000 person-years; the proportion of deaths among persons ≥65 years of age is 11.3× higher than that among the general population (). In addition, previous pandemic influenza–related excess deaths in Singapore are comparable to those in temperate countries (). In April 2009, a novel influenza A virus (H1N1) of swine origin emerged in the United States () and triggered alarm about its pandemic potential (). On June 11, 2009, the World Health Organization announced that the virus had become pandemic; it is now referred to as pandemic (H1N1) 2009 virus (). We report on enhanced influenza surveillance in Singapore that was implemented before the first case of pandemic (H1N1) 2009 was detected on May 26, 2009, and we describe the transition in Singapore from influenza cases caused predominantly by seasonal influenza to cases caused exclusively by pandemic (H1N1) 2009 virus.

The Study

This surveillance study was approved by the Chairman of Medical Board, Tan Tock Seng Hospital (TTSH), Singapore. The clinical study was approved by the Domain Specific Review Board, National Healthcare Group, Singapore. On April 25, 2009, Singapore’s Ministry of Health initiated containment measures in response to pandemic (H1N1) 2009. Travelers returning from affected countries to Singapore with acute febrile respiratory illness were screened at the TTSH emergency department, the designated screening center for pandemic (H1N1) 2009. Thermal screening was conducted at all border entry points, and the mass media publicized nationwide that persons with a risk for pandemic (H1N1) 2009 virus infection based on travel history, fever, and respiratory symptoms should go to the TTSH emergency department for screening. Combined nasal and throat swab specimens were tested with an in-house, gel-based PCR for influenza A, H1, H3, H5, N1, and N2. All specimens with subtype H1N1–positive test results underwent in-house, probe-based influenza (H1N1) 2009 PCR, and partial sequencing of the matrix gene was conducted to confirm positive PCR results. From April 27 through May 24, 2009, a total of 300 persons (244 travelers returning from affected countries with a respiratory illness and 56 symptomatic contacts) were screened for influenza infection: 24.0% had subtype H3N2, 1.6% had seasonal subtype H1N1, and 2.7% had influenza B. The median age of patients was 36 years (range 10–70 years), and 14.7% had other illnesses (asthma [52.3% of those with other illnesses], diabetes mellitus [29.5%], heart disease [11.4%], cancer [4.5%], and HIV [4.5%]). Fever was reported for 92.9% of all screened persons, cough for 82.4%, sore throat for 57.6%, rhinorrhea for 62.4%, myalgia for 25.9%, headache for 16.5%, and gastrointestinal symptoms for 9.4%. Two thirds of the patients with influenza-positive PCR results met the criteria for influenza-like illness (ILI) as defined by the US Centers for Disease Control and Prevention (CDC) (). Patients who met these criteria were more likely than those who did not to have influenza-positive PCR results (odds ratio [OR] 8.1, 95% confidence interval [CI] 4.6–14.3, p = 0.0001). Compared with contacts who had no recent travel, travelers returning from North America were less likely to have influenza-positive PCR test results (OR 0.13, 95% CI 0.06–0.27, p = 0.0001). To enhance detection of pandemic (H1N1) 2009, we obtained nasal and throat swab samples on May 2 and 3, 2009, from all hospitalized patients with clinically suspected pneumonia, regardless of their travel history. The samples were tested by PCR for influenza. A total of 146 patients were screened, of whom 21 (14.4%) were positive for influenza; 10.3% of the 146 patients had H3N2, 1.4% had seasonal H1N1, and 2.7% had influenza B. The median age of these patients was 67 years (range 20–95 years), and their median hospital stay at screening was 1 day (range 0–17 days). Of the patients, 52% were male, and 86% had other illnesses. At the time of admission, 90% of patients had a fever, 76% had a cough, 24% had a sore throat, 52% had rhinorrhea, 24% had myalgia, and 19% had headache. Findings on chest radiographs were abnormal for 10 patients (48%), of whom 5 had findings consistent with pneumonia. All but 1 patient were treated with antimicrobial drugs; none was given antiviral drug therapy. The median hospital stay was 5 days (range 1–38 days). Two patients died; both had multiple illnesses. In addition, during May 2–8, 2009, as part of nationwide enhanced influenza surveillance, nasal and throat swab specimens from patients screened at the TTSH emergency department were tested by PCR for influenza virus. The patients had fever or respiratory symptoms but no history of travel to an affected country. Overall, 95 patients were screened, of whom 30 (31.6%) had positive results for influenza; 24.2% of the 95 patients had H3N2 and 7.4% had influenza B. Fever was reported for 69.5% of the 95 patients, cough for 75.8%, sore throat for 56.8%, rhinorrhea for 58.9%, myalgia for 16.8%, and headache for 44.2%. Of the 30 patients with PCR results positive for influenza, 22 (73%) met the criteria for ILI. Compared with patients who did not meet these criteria, patients who did meet them were 3× more likely to have influenza-positive PCR results (OR 3.02, 95% CI 1.17–7.75, p = 0.019). Only 6 (6.3%) of the 95 patients had self-reported influenza vaccination in the preceding 6 months. Screening of patients with ILI symptoms continued at the TTSH emergency department, and from May 3 through June 13, 2009, only seasonal influenza (predominantly virus subtype H3N2) was detected. Pandemic (H1N1) 2009 was first detected during the week beginning June 14, and the weekly incidence rapidly increased until the week ending July 25, when all influenza cases were caused by pandemic (H1N1) 2009 virus (Figure).
Figure

Influenza-positive test results for surveillance samples obtained at the emergency department, Tan Tock Seng Hospital, Singapore, May 3–July 25, 2009. An epidemiologic week starts on a Sunday and ends on a Saturday (e.g., week 18 started on May 3 and week 29 on July 19). *Undetermined influenza A subtypes.

Influenza-positive test results for surveillance samples obtained at the emergency department, Tan Tock Seng Hospital, Singapore, May 3–July 25, 2009. An epidemiologic week starts on a Sunday and ends on a Saturday (e.g., week 18 started on May 3 and week 29 on July 19). *Undetermined influenza A subtypes. By July 25, 2009, a total of 838 patients with pandemic (H1N1) 2009 virus infection had been seen at the TTSH emergency department. The median age of patients was 22 years (range 10–90 years). Fever was reported for 85.3%, cough for 87.2%, sore throat for 55.4%, rhinorrhea for 41.6%, myalgia for 11.1%, and headache for 11.0%; 57% of patients met the CDC criteria for ILI. Patients with pandemic (H1N1) 2009 were significantly younger (p = 0.0001) than patients with seasonal influenza, but the proportion with ILI in each group was similar (OR 0.65, 95% CI 0.41–1.04, p = 0.071).

Conclusions

Each year in the United States, seasonal influenza accounts for >200,000 hospitalizations and 41,000 deaths, and it is the seventh leading cause of death (). The effect of seasonal influenza in the tropics is less well studied. In Thailand, influenza was detected in 11%–12.5% of patients with community-acquired pneumonia and in 23% of outpatients with ILI (,). Enhanced influenza surveillance in Singapore in response to pandemic (H1N1) 2009 yielded a high prevalence of seasonal influenza: 28.3% (85 of 300) among returning travelers and their contacts with respiratory symptoms, 14.4% (21 of 146) among hospitalized patients with suspected pneumonia, and 31.6% (30 of 95) among patients self-reporting to the TTSH emergency department with fever and respiratory symptoms but without a history of travel to affected countries. These findings reflect the peak local influenza season (,,). The risk of having seasonal influenza was lower among travelers returning from North America, a finding that was consistent with the timing of the peak local influenza season and the noninfluenza season in the Northern Hemisphere. Of 21 patients with influenza-positive PCR results, only 5 had radiographic evidence of pneumonia despite having a pneumonia diagnosis based on an acute history of fever and cough. No patients, including those with positive test results, were treated with antiviral drugs. This finding, in addition to low influenza vaccine coverage in Singapore, reflects the underappreciation of influenza by doctors in this country. Of note, 67%–73% of the patients with influenza-positive PCR results met the CDC ILI criteria during the study period; this finding may guide testing for seasonal influenza during peak influenza seasons in May–June and December. Its value in nonpeak seasons, however, requires further evaluation because influenza occurs year-round in the tropics (). Temperature >38°C and either cough or sore throat () were the most specific screening criteria and had the best positive predictive value; temperature of 37.5°C and either cough, sore throat, or rhinorrhea were the most sensitive screening criteria and had the best negative predictive value for influenza (Table).
Table

Performance of influenza screening criteria for travelers returning to Singapore and their contacts, April 27­–May 24, 2009

Screening criteriaSensitivity, %Specificity, %Positive predictive value, %Negative predictive value, %
Temperature >37.5°C and cough or sore throat74.171.650.887.5
Temperature >37.5°C and cough, sore throat, or rhinorrhea81.271.252.790.5
Temperature >37.8°C and cough or sore throat (9)67.180.057.086.0
Temperature >38°C and cough or sore throat (13)54.187.062.282.7
Our findings highlight a high prevalence of seasonal influenza during peak times in Singapore; the prevalence is comparable to that during typical influenza seasons in temperate countries in the Southern Hemisphere. This prevalence underscores the need for not neglecting seasonal influenza and for a more robust surveillance system to be in place for community and hospital monitoring in Singapore.
  10 in total

1.  Epidemiological data on influenza in Asian countries.

Authors:  A W Hampson
Journal:  Vaccine       Date:  1999-07-30       Impact factor: 3.641

2.  The cost of influenza in Thailand.

Authors:  James Mark Simmerman; Jongkol Lertiendumrong; Scott F Dowell; Timothy Uyeki; Sonja J Olsen; Malinee Chittaganpitch; Supamit Chunsutthiwat; Viroj Tangcharoensathien
Journal:  Vaccine       Date:  2006-01-19       Impact factor: 3.641

3.  Influenza in the tropics.

Authors:  Yee-Sin Leo; David C Lye; Angela Chow
Journal:  Lancet Infect Dis       Date:  2009-08       Impact factor: 25.071

4.  Mortality due to influenza in the United States--an annualized regression approach using multiple-cause mortality data.

Authors:  Jonathan Dushoff; Joshua B Plotkin; Cecile Viboud; David J D Earn; Lone Simonsen
Journal:  Am J Epidemiol       Date:  2005-11-30       Impact factor: 4.897

5.  Prevalence, clinical presentations and complications among hospitalized children with influenza pneumonia.

Authors:  R Samransamruajkit; T Hiranrat; T Chieochansin; S Sritippayawan; J Deerojanawong; N Prapphal; Y Poovorawan
Journal:  Jpn J Infect Dis       Date:  2008-11       Impact factor: 1.362

6.  Emergence of a novel swine-origin influenza A (H1N1) virus in humans.

Authors:  Fatimah S Dawood; Seema Jain; Lyn Finelli; Michael W Shaw; Stephen Lindstrom; Rebecca J Garten; Larisa V Gubareva; Xiyan Xu; Carolyn B Bridges; Timothy M Uyeki
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

7.  Seasonal trends of viral respiratory tract infections in the tropics.

Authors:  F T Chew; S Doraisingham; A E Ling; G Kumarasinghe; B W Lee
Journal:  Epidemiol Infect       Date:  1998-08       Impact factor: 2.451

8.  Influenza pandemics in Singapore, a tropical, globally connected city.

Authors:  Vernon J Lee; Mark I Chen; Slew Pang Chan; Chia Siong Wong; Jeffery Cutter; Kee Tai Goh; Paul Anath Tambyah
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

9.  Pandemic potential of a strain of influenza A (H1N1): early findings.

Authors:  Christophe Fraser; Christl A Donnelly; Simon Cauchemez; William P Hanage; Maria D Van Kerkhove; T Déirdre Hollingsworth; Jamie Griffin; Rebecca F Baggaley; Helen E Jenkins; Emily J Lyons; Thibaut Jombart; Wes R Hinsley; Nicholas C Grassly; Francois Balloux; Azra C Ghani; Neil M Ferguson; Andrew Rambaut; Oliver G Pybus; Hugo Lopez-Gatell; Celia M Alpuche-Aranda; Ietza Bojorquez Chapela; Ethel Palacios Zavala; Dulce Ma Espejo Guevara; Francesco Checchi; Erika Garcia; Stephane Hugonnet; Cathy Roth
Journal:  Science       Date:  2009-05-11       Impact factor: 47.728

10.  Influenza-associated deaths in tropical Singapore.

Authors:  Angela Chow; Stefan Ma; Ai Ee Ling; Suok Kai Chew
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883

  10 in total
  16 in total

1.  Pandemic influenza (H1N1) 2009 is associated with severe disease in India.

Authors:  Akhilesh C Mishra; Mandeep S Chadha; Manohar L Choudhary; Varsha A Potdar
Journal:  PLoS One       Date:  2010-05-07       Impact factor: 3.240

2.  Epidemiological and virological characteristics of influenza in the Western Pacific Region of the World Health Organization, 2006-2010.

Authors: 
Journal:  PLoS One       Date:  2012-05-29       Impact factor: 3.240

3.  Serological response in RT-PCR confirmed H1N1-2009 influenza a by hemagglutination inhibition and virus neutralization assays: an observational study.

Authors:  Mark I Chen; Ian G Barr; Gerald C H Koh; Vernon J Lee; Caroline P S Lee; Robert Shaw; Cui Lin; Jonathan Yap; Alex R Cook; Boon Huan Tan; Jin Phang Loh; Timothy Barkham; Vincent T K Chow; Raymond T P Lin; Yee-Sin Leo
Journal:  PLoS One       Date:  2010-08-30       Impact factor: 3.240

4.  Dynamic patterns of circulating seasonal and pandemic A(H1N1)pdm09 influenza viruses from 2007-2010 in and around Delhi, India.

Authors:  Shobha Broor; Anand Krishnan; Dipanjan S Roy; Shivram Dhakad; Samander Kaushik; Muneer A Mir; Yashpal Singh; Ann Moen; Mandeep Chadha; Akhilesh C Mishra; Renu B Lal
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

5.  Risk factors for pandemic (H1N1) 2009 seroconversion among adults, Singapore, 2009.

Authors:  Wei-Yen Lim; Cynthia H J Chen; Yi Ma; Mark I C Chen; Vernon J M Lee; Alex R Cook; Linda W L Tan; Norberto Flores Tabo; Ian Barr; Lin Cui; Raymond T P Lin; Yee Sin Leo; Kee Seng Chia
Journal:  Emerg Infect Dis       Date:  2011-08       Impact factor: 6.883

6.  Emergence of 2009A/H1N1 cases in a tertiary care hospital in New Delhi, India.

Authors:  Shobha Broor; Swati Gupta; Sarita Mohapatra; Samander Kaushik; Muneer A Mir; Priti Jain; Lalit Dar; Renu B Lal
Journal:  Influenza Other Respir Viruses       Date:  2011-08-04       Impact factor: 4.380

7.  Influenza seasonality and vaccination timing in tropical and subtropical areas of southern and south-eastern Asia.

Authors:  Siddhartha Saha; Mandeep Chadha; Abdullah Al Mamun; Mahmudur Rahman; Katharine Sturm-Ramirez; Malinee Chittaganpitch; Sirima Pattamadilok; Sonja J Olsen; Ondri Dwi Sampurno; Vivi Setiawaty; Krisna Nur Andriana Pangesti; Gina Samaan; Sibounhom Archkhawongs; Phengta Vongphrachanh; Darouny Phonekeo; Andrew Corwin; Sok Touch; Philippe Buchy; Nora Chea; Paul Kitsutani; Le Quynh Mai; Vu Dinh Thiem; Raymond Lin; Constance Low; Chong Chee Kheong; Norizah Ismail; Mohd Apandi Yusof; Amado Tandoc; Vito Roque; Akhilesh Mishra; Ann C Moen; Marc-Alain Widdowson; Jeffrey Partridge; Renu B Lal
Journal:  Bull World Health Organ       Date:  2014-02-24       Impact factor: 9.408

8.  Prevalence of seasonal influenza viruses and pandemic H1N1 virus in Beijing from 2008 to 2012.

Authors:  Shujuan Cui; Lili Tian; Xiaomin Peng; Guilan Lu; Weixian Shi; Dongmei Meng; Quanyi Wang
Journal:  Ann Lab Med       Date:  2012-10-17       Impact factor: 3.464

Review 9.  A review of the evidence to support influenza vaccine introduction in countries and areas of WHO's Western Pacific Region.

Authors:  Gina Samaan; Michelle McPherson; Jeffrey Partridge
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

10.  Epidemiological characterization of influenza A(H1N1)pdm09 cases from 2009 to 2010 in Baguio City, the Philippines.

Authors:  Rochelle R Pamaran; Taro Kamigaki; Teresita T Hewe; Korrine Madeleine C Flores; Edelwisa S Mercado; Portia P Alday; Alvin G Tan; Hitoshi Oshitani; Remigio M Olveda; Veronica L Tallo
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.